According to the latest market research report, published by KD Market Insights covers a detailed analysis of, “Antiviral Therapeutics Market 2014: Market Size, Trends & Opportunity Outlook – Forecast to 2024.” The study comprises of major industry trends and insights that play an important role in the market growth. Also, the report covers forecast revenue growth at global, regional and country levels, providing a detailed analysis of the industry.

The antiviral therapeutics market is anticipated to flourish at a CAGR of 5.8% over the forecast period i.e. 2019-2024. Further, the market for antiviral therapeutics was valued at USD XXX.X million in 2018.

Get Sample Report: https://www.kdmarketinsights.com/sample/5404

Growth Drivers – Antiviral Therapeutics Market

Increasing Prevalence of HIV Infection

Rising prevalence of HIV and hepatitis C infections across the globe is resulting in increased demand for antiviral therapeutics. According to the World Health Organization, in 2018, 37.9 Million were living with HIV in the world. Further, according to another WHO report, an estimated 71 million people are suffering from chronic hepatitis C virus infection. Antiviral drugs can treat more than 95% of hepatitis C patients. However, lack of access to diagnosis and treatment is resulting in low treatment ratio. Further, various healthcare organizations and governments are working on reducing the death rate and providing healthcare access to people. This factor is anticipated to strengthen the growth of global antiviral therapeutics market during the forecast period.

Launch of New Drugs

Various leading pharmaceutical companies are focusing on the introduction of new and effective drugs in the market. Furthermore, upcoming patent expiry of few drugs is anticipated to increase the flow of generic drugs in the market. These factors are envisioned to bolster the growth of antiviral therapeutics market.

Barriers – Antiviral Therapeutics Market

High Cost of Therapeutic Treatment

Factors such as high cost of antiviral drug treatment are hindering the growth of global antiviral therapeutics. Moreover, the growing use of natural products and the high cost of developing drugs is also acting as a restraint for global antiviral therapeutics market.

Segmentation Analysis

The antiviral therapeutics market by type is segmented into generic and branded. The market for generic captured the highest percentage in 2018. Moreover, it is anticipated to continue its dominance during the forecast period. In drug type segment, HIV antiviral drugs segment is anticipated to capture the largest percentage share of the market.

Further, global antiviral therapeutics market is also segmented by distribution channel into hospital pharmacy, retail pharmacy store, and online pharmacy. Retail pharmacy segment captured high market share during the forecast period. However, online pharmacy is anticipated to witness the highest growth in the upcoming years. Factors such as increasing penetration of internet and rising online pharmacies across the world are anticipated to bolster the growth of antiviral drugs online retailing market.

Geographical Analysis

Geographically, the report offers an analysis of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In the antiviral therapeutics market, North America accounted for the largest percentage of the market in global antiviral therapeutics market. Increasing prevalence of HIV infections and hepatitis C in North America is anticipated to further drive the growth of North America antiviral therapeutics market. According to U.S. Department of Health & Human Services, about 1.1 million people were living with HIV in 2017. Moreover, around 38,700 new patients were diagnosed in 2016. This factor is anticipated to pave the way for the growth of North America antiviral therapeutics market. Asia Pacific antiviral therapeutics market is anticipated to witness robust growth during the forecast period. Increasing base of the target population and the rising presence of leading pharmaceutical companies is anticipated to impel the growth of Asia Pacific antiviral therapeutics market.

Competitive Landscape
The report profiles various major market players such as
– AbbVie Inc.
– Bristol-Meyrs Squibb Company
– Cipla Inc.
– F. Hoffmann-La Roche Ltd
– Gilead Sciences Inc
– GlaxoSmithKline Plc
– Johnson & Johnson
– Merck & Co. Inc.
– Pfizer Inc.
– Sanofi
– Other Major & Niche Players

Competitive landscape analysis provides detailed strategic analysis of the company’s business and performance such as financial information, revenue breakup by segment and by geography, SWOT Analysis, key facts, company overview, business strategy, key product offerings, marketing and distribution strategies, new product development, recent news (acquisition, expansion, technology development, research & development and other market activities).

Get Complete Research Report with TOC @: https://www.kdmarketinsights.com/product/5404/antiviral-therapeutics-market

Table Of Content:

1. Preface

1.1. Research Methodology

1.2. Geographic Scope

1.3. Years Considered

2. Executive Summary

3. Market Overview

3.1. Antiviral Therapeutics Overview

3.2. Market Definition & Key Market Segments

3.3. Industry Development

3.4. Global Market Maturity

3.4.1. North America

3.4.2. Europe

3.4.3. Asia Pacific

3.4.4. Latin America

3.4.5. Middle East & Africa

3.5. Porter’s Five Force Analysis

3.6. Industry Value Chain Analysis

3.7. Macro-Economic Trends

4. Competitive Landscape

4.1. Global Antiviral Therapeutics Market 2018

4.2. Global Antiviral Therapeutics Market Value Share, By Company 2018

4.3. Global Antiviral Therapeutics Market Volume Share, By Company 2018

5. Growth Drivers & Barriers in Global Antiviral Therapeutics Market

5.1. North America

5.2. Europe

5.3. Asia Pacific

5.4. Rest of World

6. Trends in Global Antiviral Therapeutics Market

6.1. North America

6.2. Europe

6.3. Asia Pacific

6.4. Rest of World

7. Global Antiviral Therapeutics Market

7.1. Introduction

7.2. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

8. Global Antiviral Therapeutics Market Segmentation Analysis, By Type

8.1. Introduction

8.2. Strategic Insights

8.2.1. BPS Analysis, By Type

8.2.2. Market Attractiveness, By Type

8.3. Generic

8.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

8.4. Branded

8.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

9. Global Antiviral Therapeutics Market Segmentation Analysis, By Drug Type

9.1. Introduction

9.2. Strategic Insights

9.2.1. BPS Analysis, By Drug Type

9.2.2. Market Attractiveness, By Drug Type

9.3. Herpes Antiviral Drugs

9.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

9.4. Hepatitis Antiviral Drugs

9.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

9.5. HIV Antiviral Drugs

9.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

9.6. Influenza Antiviral Drugs

9.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

9.7. Others Antiviral Drugs

9.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

10. Global Antiviral Therapeutics Market Segmentation Analysis, By Mechanism of Action

10.1. Introduction

10.2. Strategic Insights

10.2.1. BPS Analysis, By Mechanism of Action

10.2.2. Market Attractiveness, By Mechanism of Action

10.3. Nucleotide Polymerase Inhibitor

10.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

10.4. Reverse Transcriptase Inhibitor

10.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

10.5. Protease Inhibitor

10.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

11. Global Antiviral Therapeutics Market Segmentation Analysis, By Distribution Channel

11.1. Introduction

11.2. Strategic Insights

11.2.1. BPS Analysis, By Distribution Channel

11.2.2. Market Attractiveness, By Distribution Channel

11.3. Hospital Pharmacy Store

11.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

11.4. Retail Pharmacy Store

11.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

11.5. Online Pharmacy

11.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12. Geographical Analysis

12.1. Introduction

12.2. North America Antiviral Therapeutics Market

12.2.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.2. By Type

12.2.2.1. Introduction

12.2.2.2. Strategic Insights

12.2.2.2.1. BPS Analysis, By Type

12.2.2.2.2. Market Attractiveness, By Type

12.2.2.3. Generic

12.2.2.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.2.4. Branded

12.2.2.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.3. By Drug Type

12.2.3.1. Introduction

12.2.3.2. Strategic Insights

12.2.3.2.1. BPS Analysis, By Drug Type

12.2.3.2.2. Market Attractiveness, By Drug Type

12.2.3.3. Herpes Antiviral Drugs

12.2.3.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.3.4. Hepatitis Antiviral Drugs

12.2.3.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.3.5. HIV Antiviral Drugs

12.2.3.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.3.6. Influenza Antiviral Drugs

12.2.3.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.3.7. Others Antiviral Drugs

12.2.3.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.4. By Mechanism of Action

12.2.4.1. Introduction

12.2.4.2. Strategic Insights

12.2.4.2.1. BPS Analysis, By Mechanism of Action

12.2.4.2.2. Market Attractiveness, By Mechanism of Action

12.2.4.3. Nucleotide Polymerase Inhibitor

12.2.4.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.4.4. Reverse Transcriptase Inhibitor

12.2.4.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.4.5. Protease Inhibitor

12.2.4.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.5. By Distribution Channel

12.2.5.1. Introduction

12.2.5.2. Strategic Insights

12.2.5.2.1. BPS Analysis, By Distribution Channel

12.2.5.2.2. Market Attractiveness, By Distribution Channel

12.2.5.3. Hospital Pharmacy Store

12.2.5.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.5.4. Retail Pharmacy Store

12.2.5.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.5.5. Online Pharmacy

12.2.5.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.6. By Country

12.2.6.1. Introduction

12.2.6.2. Strategic Insights

12.2.6.2.1. BPS Analysis, By Country

12.2.6.2.2. Market Attractiveness, By Country

12.2.6.3. U.S. Antiviral Therapeutics Market

12.2.6.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.2.6.4. Canada Antiviral Therapeutics Market

12.2.6.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3. Europe Antiviral Therapeutics Market

12.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.2. By Type

12.3.2.1. Introduction

12.3.2.2. Strategic Insights

12.3.2.2.1. BPS Analysis, By Type

12.3.2.2.2. Market Attractiveness, By Type

12.3.2.3. Generic

12.3.2.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.2.4. Branded

12.3.2.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.3. By Drug Type

12.3.3.1. Introduction

12.3.3.2. Strategic Insights

12.3.3.2.1. BPS Analysis, By Drug Type

12.3.3.2.2. Market Attractiveness, By Drug Type

12.3.3.3. Herpes Antiviral Drugs

12.3.3.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.3.4. Hepatitis Antiviral Drugs

12.3.3.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.3.5. HIV Antiviral Drugs

12.3.3.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.3.6. Influenza Antiviral Drugs

12.3.3.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.3.7. Others Antiviral Drugs

12.3.3.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.4. By Mechanism of Action

12.3.4.1. Introduction

12.3.4.2. Strategic Insights

12.3.4.2.1. BPS Analysis, By Mechanism of Action

12.3.4.2.2. Market Attractiveness, By Mechanism of Action

12.3.4.3. Nucleotide Polymerase Inhibitor

12.3.4.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.4.4. Reverse Transcriptase Inhibitor

12.3.4.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.4.5. Protease Inhibitor

12.3.4.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.5. By Distribution Channel

12.3.5.1. Introduction

12.3.5.2. Strategic Insights

12.3.5.2.1. BPS Analysis, By Distribution Channel

12.3.5.2.2. Market Attractiveness, By Distribution Channel

12.3.5.3. Hospital Pharmacy Store

12.3.5.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.5.4. Retail Pharmacy Store

12.3.5.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.5.5. Online Pharmacy

12.3.5.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.6. By Country

12.3.6.1. Introduction

12.3.6.2. Strategic Insights

12.3.6.2.1. BPS Analysis, By Country

12.3.6.2.2. Market Attractiveness, By Country

12.3.6.3. Germany Antiviral Therapeutics Market

12.3.6.3.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.6.4. United Kingdom Antiviral Therapeutics Market

12.3.6.4.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.6.5. France Antiviral Therapeutics Market

12.3.6.5.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.6.6. Italy Antiviral Therapeutics Market

12.3.6.6.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.6.7. Spain Antiviral Therapeutics Market

12.3.6.7.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.6.8. Russia Antiviral Therapeutics Market

12.3.6.8.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

12.3.6.9. Rest of Europe Antiviral Therapeutics Market

12.3.6.9.1. Historical Market Value 2014-2017 Market Value Forecast & Y-o-Y Growth Analysis, 2018-2024

Continue:

Get Exclusive Discount on This Report:  https://www.kdmarketinsights.com/discount/5404

About Us:

KD Market Insights offers a comprehensive database of syndicated research studies, customized reports, and consulting services. These reports are created to help in making smart, instant and crucial decisions based on extensive and in-depth quantitative information, supported by extensive analysis and industry insights.

Our dedicated in-house team ensures the reports satisfy the requirement of the client. We aim at providing value service to our clients. Our reports are backed by extensive industry coverage and is made sure to give importance to the specific needs of our clients. The main idea is to enable our clients to make an informed decision, by keeping them and ourselves up to date with the latest trends in the market.

Contact Us:

KD Market Insights

150 State Street, Albany,

New York, USA 12207

Telephone: +1 (520) 300-1215

Email: sales@kdmarketinsights.com

Website: www.kdmarketinsights.com 
Read More:  https://gunja1.blogspot.com/

https://consumer22.blogspot.com/

https://automotivemarketinsights.blogspot.com/

https://ictindustrynetwork.blogspot.com/

https://foodbeveragesreport.blogspot.com/

https://healthandcareindustry.blogspot.com/